APTO

JonesTrading analyst Soumit Roy maintained a Buy rating on Aptose Biosciences (APTO - Research Report) today and set a price target of $5.00. The company's shares closed yesterday at $0.50.According to TipRanks, Roy is a 4-star analyst with an average return of 7.3% and a 32.99% success rate. Roy covers the Healthcare sector, focusing on stocks such as Curis, Aeglea Biotherapeutics, and AVEO Pharma.Aptose Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $9.00, a 1,704.33% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $12.00 price target.
https://www.tipranks.com/news/blurbs/jonestrading-remains-a-buy-on-aptose-biosciences-apto?utm_source=advfn.com&utm_medium=referral